Director and Principal Investigator
Dr. John M. Vierling, professor of medicine and surgery, chief of hepatology and director of Advanced Liver Therapies at Baylor College of Medicine discusses Non-Alcoholic Fatty Liver Disease (NAFLD) risks, treatments and clinical trials.